Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-04-30FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for SELARSDI (ustekinumab-aekn) from Teva Pharmaceuticals USA, Inc., representing an approval of a b…
-
FDA approval · 2025-04-30FDA Approved: OTULFI — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for OTULFI (ustekinumab-aauz) from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-04-30FDA Approved: STEQEYMA — Original Application (CELLTRION USA, Inc.)
The FDA approved STEQEYMA (ustekinumab-stba) from Celltrion USA, Inc. under an Original Biologics License Application.
-
FDA approval · 2025-04-30FDA Approved: YESINTEK — Original Application (Biocon Biologics Inc.)
The FDA approved Yesintek (ustekinumab) from Biocon Biologics Inc. under an original Biologics License Application. It is indicated for plaq…
-
FDA approval · 2025-04-30FDA Approved: OTULFI — Original Application (Fresenius Kabi USA, LLC)
OTULFI (USTEKINUMAB-AAUZ) received FDA approval under an Original Application from Fresenius Kabi USA, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-28FDA Approved: STEQEYMA — Supplemental Application (CELLTRION USA, Inc.)
The FDA approved a supplemental application for STEQEYMA (ustekinumab-stba) from Celltrion USA, Inc.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
Real-world study evaluating the effectiveness of ustekinumab in patients with inflammatory bowel disease (Crohn's disease or ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Pharmacokinetic Study of Ustekinumab in Pediatric Subjects With Moderately to Severely Active Crohn's Disease [Phase 1]
A Phase 1 pharmacokinetic study evaluated ustekinumab in pediatric patients with moderately to severely active Crohn's disease. The study st…
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease
This report covers a completed study evaluating infliximab in Chinese children with Crohn's disease. The sponsorship is Johnson & Johnson (C…
-
CLINICAL_TRIALS withdrawal · 2025-04-27Clinical Trial Update: A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease [Phase 2]
A Phase 2 study evaluating JNJ-64304500 as add-on therapy for active Crohn's disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: "Tasty&Healthy" Dietary Approach for Crohn's Disease [NA]
A clinical trial evaluating the 'Tasty&Healthy' dietary approach for Crohn's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers
The study evaluating Care4Today IBD for Crohn's disease was terminated, and no results have been reported.
-
CLINICAL_TRIALS trial_result · 2025-04-27Clinical Trial Update: Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)
This clinical trial update summarizes the safety-focused post-marketing surveillance of ustekinumab (Stelara) in Crohn's disease patients; t…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula [Phase 3]
A long-term follow-up of a Phase 3 study evaluating darvadstrocel (Alofisel) for complex perianal fistulas in Crohn's disease has completed …
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms [NA]
A pilot clinical trial evaluating whether changes in sleep timing influence symptoms in inflammatory bowel disease, including ulcerative col…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Moderately to Severely Active Crohn's Disease With an Inadequate Response to Conventional Therapy [Phase 2, Phase 3]
A pediatric Phase 2/3 trial evaluating oral ozanimod for moderately to severely active Crohn's disease has been terminated, and results have…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: A Study on the Associations Between Microribonucleic Acid Gene Polymorphisms and Crohn's Disease
This clinical trial update notes the completion of a study investigating the associations between microRNA gene polymorphisms and Crohn's di…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: The Associations of Plasminogen Activator Inhibitor-1 Gene Polymorphisms With Crohn's Disease in Chinese Patients
This clinical trial evaluated the associations of plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms with Crohn's disease in Chine…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Crohn's Disease [NA]
A protocol for a clinical trial evaluating whether an exclusion diet can alter body composition and the gut microbiome in Crohn's disease, w…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: Effects of an Intermittent Reduced Calorie Diet on Crohn's Disease [NA]
This document reports the completion of a clinical trial evaluating the effects of an intermittent reduced-calorie diet on Crohn's disease.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis
Clinical trial update on SIMBA Capsule evaluating small intestinal dysbiosis, with recruitment ongoing for several gastrointestinal and meta…
-
FDA approval · 2025-04-14FDA Approved: OTULFI — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental Biologics License Application for OTULFI (ustekinumab-AAUZ) from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease [Phase 3]
Phase 3 clinical trial evaluating TH-SC01 cell injections for treating perianal fistulas in Crohn's disease; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease [NA]
This clinical trial is evaluating fecal microbiota transplantation as a first-line treatment for active pediatric Crohn's disease and is cur…
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Upadacitinib for Refractory IBD in Asian Children and Elderly: Age-Stratified Analysis
This completed trial update presents age-stratified results of upadacitinib for refractory inflammatory bowel disease in Asian children and …